| 12466803 |
BCKDK inhibitors and/or degraders |
Leanne Marie Buzon, Kimberly O. Cameron, Kevin Francis DEBOYACE, Kevin James Filipski, Bethany Lyn Kormos +5 more |
2025-11-11 |
|
| 12378230 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2025-08-05 |
|
| 12331041 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, Edward L. Conn, John M. Curto, David James Edmonds +7 more |
2025-06-17 |
|
| 12319669 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2025-06-03 |
|
| 12065434 |
Metabolites of GLP1R agonists |
Andrew John Bessire, David James Edmonds, Amit S. Kalgutkar, Timothy Frank Ryder |
2024-08-20 |
$1,045,292,000 |
| 11858916 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, Edward L. Conn, John M. Curto, David James Edmonds +7 more |
2024-01-02 |
$249,725,000 |
| 11802121 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2023-10-31 |
$284,263,000 |
| 11673890 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, Robert L. Dow |
2023-06-13 |
$591,478,000 |
| 11542270 |
BCKDK inhibitors |
Samit Kumar Bhattacharya, Leanne Marie Buzon, Kevin James Filipski, Bethany Lyn Kormos, Luis Angel Martinez-Alsina +4 more |
2023-01-03 |
$607,007,000 |
| 11512070 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2022-11-29 |
$2,104,375,000 |
| 11059833 |
BCKDK inhibitors |
Samit Kumar Bhattacharya, Leanne Marie Buzon, Kevin James Filipski, Bethany Lyn Kormos, Luis Angel Martinez-Alsina +4 more |
2021-07-13 |
$442,539,000 |
| 10934279 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2021-03-02 |
$1,471,575,000 |
| 10851081 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2020-12-01 |
$390,003,000 |
| 10822335 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, Robert L. Dow |
2020-11-03 |
$385,583,000 |
| 10683281 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2020-06-16 |
$1,092,312,000 |
| 10676465 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2020-06-09 |
$602,135,000 |
| 10669259 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2020-06-02 |
$395,652,000 |
| 10294225 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, Robert L. Dow |
2019-05-21 |
$472,672,000 |
| 10208019 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2019-02-19 |
$915,842,000 |
| 9908883 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, Robert L. Dow |
2018-03-06 |
$304,169,000 |
| 9181252 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
Robert L. Dow, Scott W. Bagley, Aaron Smith |
2015-11-10 |
$341,611,000 |
| 9145416 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, Robert L. Dow |
2015-09-29 |
$193,164,000 |
| 9139587 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Scott W. Bagley, Daniel Wei-Shung Kung |
2015-09-22 |
$161,915,000 |
| 8993586 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
Robert L. Dow, Scott W. Bagley, Aaron Smith |
2015-03-31 |
$327,329,000 |
| 8859577 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, Robert L. Dow |
2014-10-14 |
$166,604,000 |
